Skip to content
TrustList
Amgen logo
Venture capital firm

Amgen

Biotechnology company that discovers, develops, manufactures and delivers medicines for serious diseases

Amgen cover

About Amgen

Medicines made from living cells

Amgen describes itself as a pioneer in using living cells to make biologic medicines. The company discovers, develops, manufactures and delivers treatments for serious illnesses, and it says its medicines typically go to diseases where few treatment options exist. Its framing is that it brings together biology and technology to reach millions of patients, and that its aim goes beyond making medicines to making a positive difference in the world.

Research and the pipeline

The science section of its site is organized around its research and development strategy and a published pipeline of medicines in development. Related material includes science podcasts and scientific advisory boards. The company also runs competitive grants for outside researchers, and a biosimilars business that supplies versions of existing biologic medicines. Recent stories on the site cover work in areas such as atopic dermatitis, thyroid eye disease, Sjögren's disease and a rare immune-related condition, along with the role of AI in drug discovery.

Clinical trials

Amgen publishes a clinical trials area that serves both patients and healthcare professionals. It explains what a trial involves and lists Amgen studies. It also covers diversity and representation in trials, and sets out practices on transparency, data sharing and disclosure. For doctors there is a clinical out-of-hours support program, and the company supports investigator-sponsored studies run by outside researchers.

Supporting the scientific community

The company backs several outreach programs: an educational outreach program, a postdoctoral fellows program, scientific conferences and a start-up network program that connects it with early companies.

Manufacturing and product safety

Manufacturing is presented through three themes of innovation, quality and reliability. The products area carries medical information, a statement on counterfeit drugs and safety data sheets, and a global patient safety section explains how adverse events and product complaints are reported.

Responsibility reporting

Its responsibility pages cover environmental, social and governance strategy under the headings of healthy people, a healthy society, a healthy planet and a healthy Amgen. Topics include access to medicines, health equity, diversity and inclusion, supplier diversity, community investment through its foundation, environmental sustainability, ethical research, cybersecurity and data privacy. Investors and the press are served with financial results, press releases and corporate governance material.

TrustList summary

Amgen is a biotechnology company. It researches, develops, manufactures and distributes medicines for serious illnesses, and describes its work as combining biology with technology.

Products and services

  • Medicines: treatments developed from its own research pipeline.
  • Biosimilars: versions of existing biologic medicines.
  • Clinical trials: studies with information for patients and healthcare professionals.
  • Science outreach: competitive research grants, fellowships, scientific conferences and a start-up network programme.
  • Manufacturing: production focused on quality and reliability.

Clients

Patients, doctors, researchers and investors. Its site also covers governance, ethics and compliance policies, and publishes financial results.

Key facts

  • Sector: Biotechnology
  • Research areas: Cancer and eye disease among many featured topics

Summary written by TrustList from the business's own published information, Nov 2026.

Categories & features

Ask TrustList to introduce you to Amgen

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Amgen

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Amgen.

Amgen alternatives

Similar listings buyers compare against this one.

Long-term Australian private investor buying and funding mid-sized businesses through partnership with managers

UK organisation running social technology award and challenge programmes that fund and mentor ventures

Venture firm investing in startups and teams in India and around the world

Venture capital firm of individuals and family offices investing in early-stage and clean technology companies

Venture capital investor backing the next generation of consumer technology companies

Venture capital fund investing in sustainable mobility and energy companies, mainly in Europe

Foundation supporting UK engineering and manufacturing through education, policy work and direct investment

Private equity group backing growth-oriented US lower middle market companies